This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
in May and June 2020. This new work-flow for clinicians led to fast-adoption of virtual care platforms – telemedicine, tele-conferencing with patients via apps like Zoom and Skype along with commercially-built telehealth channels, and the prescription and use of remote health monitoring devices placed in patients’ homes.
While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?
have struggled to pay for living expenses since December 2020, a year into the COVID-19 pandemic. Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.
Evolution and Benefits of DHTs in Neurology Trials DHTs – like wearables, mobile health apps, and telemedicine platforms – have for example significantly impacted the design and execution of neurology trials. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.
While many industries plummeted in the first quarter of the year, digital health companies closed the first quarter of 2020 with unprecedented levels of funding. Private equity and venture capital financing of digital health start-ups reached an all-time high of just over $3 billion in Q1 2020. invested across Q2 2019-Q1 2020.The
Several consumer surveys published to coincide with CES 2020 provide insights into the new consumer trust mindset across industries, but especially important for health engagement. Six in ten people told Kantar that privacy concerns like data breaches prevent them from using wearable tracking devices or using telemedicine services.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content